In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses

Sina Soleimani ^1,2, Omid Madadgar ¹, Shahla Shahsavandi ² * , Homayoon Mahravani ², Mohsen Lotfi ²

Cited by CrossRef: 4

1- Soleimani S, Shahsavandi S. Comparative Evaluation of Mx and Alum as Bio and Conventional Adjuvants in Inducing Immune Responses by Influenza DNA Vaccine. J Adv Med Biomed Res. 2021;29(137):331 [Crossref]

2- Jafari D, Malih S, Gomari M, Safari M, Jafari R, Farajollahi M. Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study. BMC Mol and Cell Biol. 2020;21(1) [Crossref]

3- Ghabeshi S, Ebrahimie E, Salimi V, Ghanizadeh A, Khodakhah F, Yavarian J, Norouzbabaei Z, Sasani F, Rezaie F, Azad T. Experimental direct-contact transmission of influenza A/H9N2 virus in the guinea pig model in Iran. Future Virology. 2020;15(5):277 [Crossref]

4- Soleimani S, Shahsavandi S, Maddadgar O. Improvement influenza HA2 DNA vaccine cellular and humoral immune responses with Mx bio adjuvant. Biologicals. 2017;46:6 [Crossref]